Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference Apr 5, 2022 07:00AM
Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference Apr 5, 2022 07:00AM
Needham & Company Reiterates Hold Rating on Zynerba Pharmaceuticals (ZYNE), Phase 3 RECONNECT Trial Remains Main Potential Value Driver Mar 1, 2022 12:06PM
Zynerba Pharmaceuticals to Present at the Needham Virtual Healthcare Conference Apr 6, 2021 07:30AM
UPDATE: Needham & Company Downgrades Zynerba Pharmaceuticals (ZYNE) to Hold Jul 1, 2020 07:22AM


Apr 10, 2020 08:00AM Zynerba Pharmaceuticals to Present at the 19th Annual Needham Virtual Healthcare Conference
Oct 21, 2019 09:21AM Pre-Open 10/21: (MDR) (OPK) (FSCT) Higher (KMT) (IPHS) (BA) Lower (more...)
Oct 21, 2019 07:06AM Needham & Company Starts Zynerba Pharmaceuticals (ZYNE) at Buy